tirzepatide approved for osa What Is Used for? and Potential Uses Zepbound (tirzepatide) is the first
Description
Doctors already know it can cause short term nausea, vomiting and diarrhea
If forced to generalize, tirzepatide edges out semaglutide for total side effect burden, but the difference is modest
The Health Sciences Authority approved tirzepatide injection injection in March 2023 for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control
While there is growing interest in whether glycine could interact with or complement tirzepatide, clinical studies evaluating this combination are currently limited , and more research is needed
